ESC Congress 2026

A transformative event to share the latest advancements in cardiovascular science

Munich (Germany)
28 - 31 August 2026

The World Heart Federation ant the European Society of Cardiology host this transformative event, where the world of cardiology comes together, “breaking down barriers and fostering collaboration to propel cardiovascular care into a new era”. ESC Congress 2026 will take place in Munich (Germany) from August 28 to 31.

You can already check the official agenda on the congress’ website. We highlight some content related to Chagas disease below:

  • 28 August from 12:15 to 13:00 – Infections and myocardial disease
    Chagas disease and all-cause mortality in a community-based cohort in Colombia
    Presenter: Sergio Alejandro Gomez Ochoa (University Hospital Heidelberg – Heidelberg, Germany)

  • 28 August from 12:15 to 13:00 – Heart failure: multiple mechanisms and solutions
    Sacubitril/Valsartan versus enalapril in heart failure due to chagas cardiomyopathy: a systematic review of randomized controlled trials
    Presenter: Muhammad Umar Soomro (Jinnah Medical and Dental Collge, Karachi – Karachi, Pakistan)

  • 29 August from 08:15 to 09:00 – Ablation of ventricular arrhythmias: right ventricular
    Electro-mechanical dissociation in Chagas cardiomyopathy: comparative analysis of arrhythmic burden beyond LVEF
    Presenter: Sergio Alejandro Gomez Ochoa (University Hospital Heidelberg – Heidelberg, Germany)

  • 29 August from 17:15 to 18:00 – Heart failure biomarkers: the cardiometabolic axis
    Association between cardiorenal biomarkers and myocardial deformation parameters in Chagas cardiomyopathy: a speckle tracking echocardiography study
    Presenter: Luis Eduardo Echeverria (Floridablanca, Colombia)

  • 29 August from 08:15 to 09:00 – Cardiac implantable electronic devices therapy: from implant strategy to long-term management
    Implantable devices in chronic Chagas cardiomyopathy: outcomes and a delayed response to CRT in a real-world cohort
    Presenter: Carlos Calderon Franco (University Hospital San Ignacio – Bogota, Colombia)

  • 31 August from 09:15 to 10:00 – HFrEF therapy: beyond current standards
    Effects of sacubitril/valsartan versus enalapril on NT-proBNP and hs-troponin T in patients with heart failure due to Chagas disease: insights from the PARACHUTE-HF trial
    Presenter: Luis Eduardo Echeverria (Floridablanca, Colombia)

Interest links

SHARE

Next events

  • EVENTO

    XXX Cumbre Iberoamericana

    Madrid (España)
    4 - 5 November 2026

  • EVENTO

    BIOSaG 2026

    Quito (Ecuador)
    23 - 25 September 2026

  • EVENTO

    World Congress of Cardiology 2026

    Rio de Janeiro (Brazil)
    8 - 10 October 2026

  • EVENTO

    Intersectoral Action to Accelerate the Elimination of Communicable Diseases

    Virtual
    11 August 2026